Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.55 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.55 |
| ▸ | ALKBH2 | Q6NS38 | 1/20 | 0.55 |
| ▸ | ALKBH3 | Q96Q83 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.54 |
| ▸ | CA2 | P00918 | 5/20 | 0.54 |
| ▸ | CA9 | Q16790 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | FBP1 | P09467 | 1/20 | 0.50 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.49 |
| ▸ | ITGAV | P06756 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL9178383 | 0.94 | SLC1A3 (0.51) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL3548718 | 0.86 | CA1 (0.52) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL3637063 | 0.85 | LMNA (0.68) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL29489589 | 0.85 | CA1 (0.55) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL6723764 | 0.85 | CA1 (0.51) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL11337623 | 0.85 | CA1 (0.51) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL3548714 | 0.85 | CA1 (0.51) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL6465947 | 0.85 | CA1 (0.55) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL11337626 | 0.85 | CA1 (0.51) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 | |
| SCHEMBL13329854 | 0.83 | CA1 (0.50) | SLC1A3SLC1A2SLC1A1ALKBH2ALKBH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0542556-B1 | Thermosensitive recording material | NEW OJI PAPER CO LTD (JP) | 1995-07-19 | — | — | EP | claimed |
| CN-105017172-B | A kind of oxazine compounds of 2 carbonyl of halogen photolytic activity 1,3 and preparation method and application | 中国科学院化学研究所 | 2017-07-14 | — | — | CN | disclosed |
| US-20100041892-A1 | Therapeutic agent for diabetes | ABE HIDENORI | 2010-02-18 | — | — | US | disclosed |
| EP-1499305-A2 | USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES | Pfizer Japan Inc. (JP) | 2005-01-26 | — | — | EP | disclosed |
| WO-2003086371-A2 | USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES | PFIZER JAPAN INC. (JP) | 2003-10-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041892-A1 | Therapeutic agent for diabetes | FABP4, SLC5A1, SLC5A2 | SLC1A3 1095/4885SLC1A2 1024/4885SLC1A1 814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.